Data was collected through survey questionnaires from national and multinational
pharmaceutical firms in Pakistan. These firms are directly involved in manufacturing
drug formulations, tablets, capsules, syrups and injectables. We selected the pharmaceutical
industry for data collection for many reasons. For instance, in the pharmaceutical sector,
MNCsincreasedtheirmarketsizeinPakistanfrom100.2billionUSdollarsinthefirstquarter
of 2016 to 143.2 billion US dollars by the end of the first quarter of 2020. In contrast, it also
fetched $1.3 million worth of foreign direct investment in April 2020.